MORGAN STANLEY - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$21,308
+28.6%
11,2740.0%0.00%
Q2 2023$16,573
-24.6%
11,2740.0%0.00%
Q1 2023$21,984
-13.3%
11,274
-0.0%
0.00%
Q4 2022$25,369
-18.2%
11,275
-12.6%
0.00%
Q3 2022$31,000
+416.7%
12,894
+384.7%
0.00%
Q2 2022$6,000
-33.3%
2,660
-15.7%
0.00%
Q1 2022$9,000
-25.0%
3,155
+18.1%
0.00%
Q4 2021$12,000
+50.0%
2,671
-15.8%
0.00%
Q3 2021$8,000
-11.1%
3,172
+0.4%
0.00%
Q2 2021$9,000
-73.5%
3,160
-71.7%
0.00%
Q1 2021$34,000
+142.9%
11,160
+131.3%
0.00%
Q4 2020$14,000
-48.1%
4,825
-43.2%
0.00%
Q3 2020$27,000
-25.0%
8,502
-22.2%
0.00%
Q2 2020$36,000
-18.2%
10,922
-10.2%
0.00%
Q1 2020$44,000
-43.6%
12,168
-20.5%
0.00%
Q4 2019$78,000
-17.9%
15,304
-4.3%
0.00%
Q3 2019$95,000
-14.4%
15,987
-8.4%
0.00%
Q2 2019$111,000
+0.9%
17,454
-8.1%
0.00%
Q1 2019$110,000
+4.8%
18,985
+8.6%
0.00%
Q4 2018$105,000
-5.4%
17,479
-10.4%
0.00%
Q3 2018$111,000
-5.9%
19,514
+1.5%
0.00%
Q2 2018$118,000
-13.9%
19,233
-5.8%
0.00%
Q1 2018$137,000
-5.5%
20,415
+3.5%
0.00%
Q4 2017$145,000
+2.1%
19,717
-1.7%
0.00%
Q3 2017$142,000
-3.4%
20,053
-4.6%
0.00%
Q2 2017$147,000
-51.0%
21,018
-51.4%
0.00%
Q1 2017$300,000
+45.6%
43,230
+15.2%
0.00%
Q4 2016$206,000
+31.2%
37,542
+20.2%
0.00%
Q3 2016$157,000
-7.1%
31,244
-16.7%
0.00%
Q2 2016$169,000
-6.6%
37,513
-7.2%
0.00%
Q1 2016$181,000
-32.5%
40,414
-20.6%
0.00%
Q4 2015$268,000
-18.8%
50,880
-11.0%
0.00%
Q3 2015$330,000
-21.1%
57,160
-2.1%
0.00%
Q2 2015$418,000
-4.6%
58,415
-11.3%
0.00%
Q1 2015$438,000
+17.4%
65,868
+5.5%
0.00%
Q4 2014$373,000
+21.1%
62,418
+0.1%
0.00%
Q3 2014$308,000
-1.0%
62,353
-9.7%
0.00%
Q2 2014$311,000
+4.0%
69,043
+3.8%
0.00%
Q1 2014$299,000
-35.4%
66,499
-26.7%
0.00%
Q4 2013$463,000
-32.8%
90,680
-40.4%
0.00%
Q3 2013$689,000
-45.7%
152,124
-38.8%
0.00%
-100.0%
Q2 2013$1,270,000248,5310.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 188,703$557,0000.43%
Sterling Financial Planning, Inc. 22,031$65,0000.05%
BERKSHIRE ASSET MANAGEMENT LLC/PA 165,495$488,0000.04%
Ariel Investments 821,096$2,422,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 151,287$445,0000.01%
Renaissance Technologies 675,159$1,992,0000.00%
DIMENSIONAL FUND ADVISORS LP 781,891$2,299,0000.00%
Oakworth Capital, Inc. 3,052$9,0000.00%
ACADIAN ASSET MANAGEMENT LLC 105,018$310,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 53,441$157,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders